Funtleyder Leslie D. — SEC Form 4 filings
SEC reporting owner CIK 1775394. 13 Form 4 filings on record with FilingPulse; latest filed 2026-02-03.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-03-18 to 2026-02-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 96,689 shares, $327,452 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 28,727 shares @ $5.39 ($154,839) in Applied Therapeutics, Inc., filed 2024-03-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Applied Therapeutics, Inc. (APLT) | Chief Financial Officer, Director | 11 | — | 5 legs · 96,689 sh · $327,452 | 16 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | Director | 2 | — | — | 2 |
Form 4 filings — Funtleyder Leslie D.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-03 | 4 | Applied Therapeutics, Inc. (APLT) | Grant/award (A): 1,187,500 @ $0 · Disposition to issuer (D): 2,375,000 · Code (U): 152,959 · Disposition to issuer (D): 20,460 (derivative) · Disposition to issuer (D): 10,230 (derivative) · Disposition to issuer (D): 16,500 (derivative) · +3 more | EDGAR |
| 2026-01-02 | 4 | Applied Therapeutics, Inc. (APLT) | Grant/award (A): 150,000 @ $0 | EDGAR |
| 2025-12-19 | 4 | REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | Grant/award (A): 8,200 (derivative) @ $0 | EDGAR |
| 2025-10-01 | 4 | Applied Therapeutics, Inc. (APLT) | Grant/award (A): 150,000 @ $0 | EDGAR |
| 2025-07-03 | 4 | Applied Therapeutics, Inc. (APLT) | Grant/award (A): 150,000 @ $0 · Grant/award (A): 150,000 @ $0 | EDGAR |
| 2025-03-26 | 4 | Applied Therapeutics, Inc. (APLT) | Grant/award (A): 350,000 @ $0 | EDGAR |
| 2025-03-06 | 4 | Applied Therapeutics, Inc. (APLT) | Sale (S): 14,502 @ $0.44 | EDGAR |
| 2025-02-07 | 4 | Applied Therapeutics, Inc. (APLT) | Sale (S): 22,950 @ $0.61 | EDGAR |
| 2024-12-20 | 4 | Applied Therapeutics, Inc. (APLT) | Grant/award (A): 150,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | Grant/award (A): 8,200 (derivative) @ $0 | EDGAR |
| 2024-08-23 | 4 | Applied Therapeutics, Inc. (APLT) | Sale (S): 13,530 @ $5.83 | EDGAR |
| 2024-06-10 | 4 | Applied Therapeutics, Inc. (APLT) | Sale (S): 16,980 @ $4.32 | EDGAR |
| 2024-03-18 | 4 | Applied Therapeutics, Inc. (APLT) | Sale (S): 28,727 @ $5.39 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1775394 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →